Immunome, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-18.2M | $-18.3M | $79.0K | $3.4M |
| FY2022 | $-28.7M | $-28.9M | $248.0K | $5.3M |
| FY2023 | $-7.6M | $-8.4M | $831.0K | $6.2M |
| FY2024 | $-110.8M | $-118.0M | $7.2M | $15.7M |
| FY2025 | $-190.9M | $-200.6M | $9.7M | $25.7M |